About Lyfstone
Lyfstone is a company based in Tromsø (Norway) founded in 1999. Lyfstone has raised $1.96 million across 1 funding round from investors including Norinnova Invest. Lyfstone offers products and services including Calprotectin Test. Lyfstone operates in a competitive market with competitors including Imagen, CD Diagnostics, Emovi, MuscleSound and Osteosys, among others.
- Headquarter Tromsø, Norway
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lyfstone Bv
-
Annual Revenue
$2.97 M (USD)-21as on Dec 31, 2021
-
Net Profit
-$600.29 K (USD)-363as on Dec 31, 2021
-
EBITDA
-$523.85 K (USD)-216as on Dec 31, 2021
-
Total Equity Funding
$1.96 M (USD)
in 1 rounds
-
Latest Funding Round
$1.96 M (USD), Unspecified
Mar 06, 2008
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lyfstone
Lyfstone offers a comprehensive portfolio of products and services, including Calprotectin Test.
Rapid bedside test for detecting joint infections using synovial fluid.
Funding Insights of Lyfstone
Lyfstone has successfully raised a total of $1.96M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $1.96 million completed in March 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lyfstone
Lyfstone has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Norinnova Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment fund focused on technology-based growth companies in Northern Norway.
|
Locked | Locked | Locked |
Investor details for Lyfstone
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lyfstone
Investment portfolio details for Lyfstone
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lyfstone
Detailed financials for Lyfstone
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lyfstone Comparisons
Peer comparison for Lyfstone
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lyfstone
Lyfstone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imagen, CD Diagnostics, Emovi, MuscleSound and Osteosys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI solutions for detecting pathologies in medical images are developed.
|
|
| Locked | Locked | Locked |
Synovial fluid is tested for biomarkers in orthopedic disorders.
|
|
| Locked | Locked | Locked |
Developer of a knee assessment device
|
|
| Locked | Locked | Locked |
Muscular glycogen levels are measured non-invasively via ultrasound.
|
|
| Locked | Locked | Locked |
Bone mineral densitometer instruments are developed and marketed globally.
|
|
| Locked | Locked | Locked |
Diagnostic tests for osteoporosis are provided via urine-based biomarkers.
|
Detailed competitors of Lyfstone
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lyfstone
Complete news archive for Lyfstone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyfstone
Lyfstone was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Lyfstone is headquartered in Tromsø, Norway. It is registered at Tromsø, Troms Og Finnmark, Norway.
Lyfstone is a funded company, having raised a total of $1.96M across 1 funding round to date.
Annual revenue of Lyfstone is $2.97M as on Dec 31, 2021.
Lyfstone was founded in 1999 in Tromso, Norway, within the medical diagnostics sector. Orthopedic tests and biomarkers are developed and supplied for diagnosing periprosthetic joint infections and implant loosening. A point-of-care lateral flow assay is employed to identify calprotectin and procalcitonin levels, supporting clinical decisions in orthopedics. Operations focus on biomarker-based solutions for healthcare providers in the region.
Lyfstone's top competitors include CD Diagnostics, Imagen and Emovi.
Lyfstone offers Calprotectin Test.
Lyfstone has 1 investor. Key investors include Norinnova Invest.